Friedreich's ataxia (FRDA) is the most common hereditary neurodegenerative disorder in humans, which, as a rule, results from the expansions of (GAA) n repeats situated in the first intron of the FXN gene (Campuzano et al., 1996) . Expanded repeats inhibit transcription of this gene either directly or by changing its chromatin structure (Kumari and Usdin, 2009 ). The ensuing decrease in the level of frataxin-a protein involved in iron homeostasis in mitochondria-is the ultimate cause of FRDA. A paper from Ku et al. (2010) in this issue describes the features of induced pluripotent stem cells (iPSCs) obtained from the fibroblasts of Friedreich's ataxia patients and provides mechanistic insight into the disease pathology that may also extend to other repeat expansion diseases.
As observed in other repeat expansion disorders, the severity of the symptoms experienced by FRDA patients correlates with the length of the expandable repeat. In this case, normal individuals carry less than 34 (GAA) n repeats, carriers contain premutation-size repeats of 35 to 70 copies, while full-mutation alleles have anywhere from 71 to up to 1700 repeats. The full-and premutation-size (GAA) n repeats are highly prone to further expansions and contractions during intergenerational transmissions. It is generally believed that contractions occur during gametogenesis, particularly spermatogenesis, while expansions predominate in early embryonic divisions (De Michele et al., 1998) .
The mechanisms and consequences of the instability of (GAA) n repeats are under investigation using a number of model systems, including bacteria, yeast, transgenic mice, and human cell cultures (Ditch et al., 2009 and references therein). However, given that, in humans, repeat expansions preferably occur during early embryonic development, it seems imperative to study this process in embryonic stem cells (ESCs) or their equivalents. Ku et al. rise to this challenge by analyzing the stability of mutant-size (GAA) n repeats and their effects on gene expression in iPSCs created by the transcription factorbased reprogramming of fibroblasts from FRDA patients.
The paper contains two principal observations. First, repression of the FXN gene, characteristic of the patients' fibroblasts, appears to be maintained in the iPSCs. Indeed, ChIP experiments confirm the presence of heterochromatin marks at expanded (GAA) n repeats in the iPSCs. Furthermore, there is a slight but telling difference in the global gene expression pattern in the FRDA versus control iPSCs, which reflects the signature of the human disease.
On first sight, this observation is counterintuitive: why does cell reprogramming, which is supposed to wipe out all epigenetic memory of a differentiated cell, leave the disease signature intact? This pattern is not without a precedent, however. A report from the Benvenisty and Daley laboratories published earlier this year in Cell Stem Cell (Urbach et al., 2010) describes what happens with the signature of another repeat expansion disease, fragile X syndrome, during cell reprogramming. Fragile X is caused by the expansion of a different (CGG) n repeat located in the 5 0 -UTR of the human FMR1 gene. Expanded alleles are expressed in ESCs but are shut down during cell differentiation. This change is attributed to the heterochromatinization of the repeat and its surrounding DNA (Kumari and Usdin, 2009) . Urbach et al. found that, in contrast to ESCs, expanded FMR1 alleles remain heterochromatinized in the iPSCs derived from the fragile X fibroblasts. Together, these results show that epigenetic marks typical of repeat expansion diseases manage to survive the process of cell reprogramming. Supported by several other recent papers, the idea that transcription factor-based reprogramming can harbor residual epigenetic signatures of the original differentiated cells emerges as a consensus in the field.
The second observation made by Ku et al. is truly striking. The authors found that the long (GAA) n repeats in the mutant FXN alleles undergo further expansion during the reprogramming of FRDA fibroblasts. Indeed, the repeat instability observed in the iPSCs was highly reminiscent of the patterns observed in studies of FRDA families. Specifically, the rate of instability was basically 100%, the length of repeats increased in discrete steps, and expansions were observed for both mutant alleles. At the same time, no expansions were detected for short (GAA) n repeats located in normal FXN alleles or two unrelated genetic loci. What happens with long (GAA) n repeats situated elsewhere in the genome during cell reprogramming remains to be studied.
Are other expandable repeats similarly unstable in the ESCs? Another recent report demonstrates that a triplet repeat, (CTG) n , expansions of which are responsible for the myotonic dystrophy type 1 (DM1) in humans, is highly unstable in DM1 ESCs, but becomes stabilized during cell differentiation (Seriola et al., 2010) . In contrast to (GAA) n repeats, however, both expansions and contractions of the (CTG) n repeats were observed in the latter case.
What molecular mechanisms could account for this stunningly high instability of a specific repeat in one particular gene (Figure 1) ? Previous studies of (CAG) n d(CTG) n repeats in Huntington's disease and myotonic dystrophy transgenic mice showed that ''hijacked'' mismatch repair machinery promotes their expansion (McMurray, 2008) . Along these lines, Ku et al. observed that the amount of the mismatch repair protein MSH2 is significantly increased in mutant iPSCs and ESCs compared to FRDA fibroblasts. Furthermore, partial knockdown of the MSH2 gene in iPSCs via lentivral shRNA decreased the scale of repeat expansions of the mutant FRDA alleles. The authors hypothesize, therefore, that repeat instability depends on the mismatch repair protein MSH2. There are two caveats to this hypothesis, however. First, MSH2 does not work alone but cooperates with either MSH3 or MSH6 proteins to form mismatch repair complexes MutSb and MutSa, respectively. Neither MSH3 nor MSH6 is overexpressed in the FRDA iPSCs. Second, a careful look at Figures 4 and S2 shows that MSH2 knockdown affected the expansion scale for just one of the two mutant alleles. Therefore, it seems likely that MSH2 is not the only explanation for the specificity of repeat expansion observed in FRDA-derived iPSCs.
What other mechanisms could be responsible for the instability of long (GAA) n repeats in the FXN locus in iPSCs? One possibility is grounded in the fact that these repeats inhibit gene expression, as RNA polymerase gets tangled in the complex structure of the DNA in this region (Ditch et al., 2009) . Stalled RNA polymerase can, in turn, trigger the pathway called gratuitous transcription-coupled repair (Hanawalt and Spivak, 2008) , futile cycles of which could result in repeat instability in the iPSC environment. Another possibility comes from a recent study demonstrating the existence of an alternative mode of replication in mammalian cells, which operates on the templates undergoing chromatin reformation and is exceptionally sensitive to the presence of structure-prone DNA repeats (Chandok et al., 2010) . It was further suggested, albeit by no means proven, that this mode of replication might be a factor during early embryonic divisions. If true, an alternative mode of replication through (GAA) n and other expandable repeats could promote their instability. Future studies are needed to distinguish between these and other possible scenarios. Fibroblasts from Friedreich's ataxia patients harbor unstable, (GAA) n repeats (red bar) that can be expanded via a variety of potential mechanisms during transcription factor-mediated reprogramming. MMR, mismatch repair; TCR, transcription-coupled repair.
